As of Monday, February 16, 2026, High-Cost Medicines for cancer patients can now be collected by up to three designated representatives, offering greater flexibility and easier access to treatment through community pharmacies.
This new possibility is particularly important for patients who require regular access to High Cost Medicines but may have difficulty getting to the pharmacy or live far from a pharmacy. By allowing representatives, care becomes more flexible and adapted to everyday needs, while ensuring the safety and correct use of the treatment. In this way, access to therapy is faster, more human-centered, and free from unnecessary hassle.
In this first phase, the option applies to patients with cancer and multiple sclerosis, and it will gradually extend to other High Cost Medicines categories. The steps for collection remain the same: the insured person logs into the platform using Taxisnet + AMKA, selects the pharmacy of their choice, and monitors the progress of their order.
For more details, see our previous article.
Text/adaptation: Ifiyenia Anastasiou for Kapa3
